Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation

Click to increase image sizeClick to decrease image size

Acknowledgements

We sincerely thank Dr. Gregory Gores of the Mayo Clinic, Rochester, MN, for his indispensable contribution to the donor information disclosure process. We thank Misako Uto, Hiroko Katsura and Mika Oka for their technical support with tissue preparation and immunohistochemical staining.

Ethics statement

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Additional information

Funding

This study was supported by the Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research, JSPS KAKENHI (Grant Number 21K07320, M.T.; 23K08056, Y.S.), and the Kumamoto University Hospital Research Revitalization Project.